Postmortem examination of the kidney in allogeneic hematopoietic stem cell transplantation recipients: Possible involvement of graft-versus-host disease

International Journal of Hematology

Volumn 87, Issue 2, 2008, Pages 225-230

  Kusumi, Eiji ^a,b   Kami, Masahiro ^b   Hara, Shigeo ^a   Hoshino, Junichi ^a   Yamaguchi, Yutaka ^c   Murashige, Naoko ^d   Kishi, Yukiko ^e   Shibagaki, Yugo ^f   Shibata, Taro ^g   Matsumura, Tomoko ^a,b   Yuji, Koichiro ^a   Masuoka, Kazuhiro ^a   Wake, Atsushi ^a   Miyakoshi, Shigesaburo ^a   Taniguchi, Shuichi ^a  

^a TORANOMON HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Japan Ministry of Health Labour and Welfare   (Japan)

^e JICHI MEDICAL UNIVERSITY   (Japan)

^f UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^g NATIONAL CANCER CENTER   (Japan)

Author keywords

Autopsy; Bone marrow transplantation; Capillaritis; Glomerulitis; Tubulitis

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; FLUDARABINE; MELPHALAN;

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTERITIS; ARTICLE; AUTOPSY; CAPILLARITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLOMERULITIS; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; KIDNEY INJURY; MALE; RENAL TUBULITIS; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; TRANSPLANTATION, HOMOLOGOUS;

EID: 42049102383     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0026-2     Document Type: Article

References (30)

1. Gruss E, Bernis C, Tomas JF, Garcia-Canton C, Figuera A, Motellon JL, et al. Acute renal failure in patients following bone marrow transplantation: prevalence, risk factors and outcome. Am J Nephrol. 1995;15(6):473-9.
2. Imai H, Oyama Y, Miura AB, Endoh M, Sakai H. Hematopoietic cell transplantation-related nephropathy in Japan. Am J Kidney Dis. 2000;36(3):474-80.
3. Zager RA. Acute renal failure in the setting of bone marrow transplantation. Kidney Int. 1994;46(5):1443-58.
4. Kennedy MS, Yee GC, McGuire TR, Leonard TM, Crowley JJ, Deeg HJ. Correlation of serum cyclosporine concentration with renal dysfunction in marrow transplant recipients. Transplantation. 1985;40(3):249-53.
5. Davies DR, Bittmann I, Pardo J. Histopathology of calcineurin inhibitor-induced nephrotoxicity. Transplantation. 2000;69 Suppl 12:SS11-3.
6. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Chapman JR, Allen RD. Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology. Transplantation. 2004;78(4):557-65.
7. Kimura S, Horie A, Hiki Y, Yamamoto C, Suzuki S, Kuroda J, et al. Nephrotic syndrome with crescent formation and massive IgA deposition following allogeneic bone marrow transplantation for natural killer cell leukemia/lymphoma. Blood. 2003;101(10):4219-21.
8. Suehiro T, Masutani K, Yokoyama M, Tokumoto M, Tsuruya K, Fukuda K, et al. Diffuse proliferative glomerulonephritis after bone marrow transplantation. Clin Nephrol. 2002;58(3):231-7.
9. Homma CI, Kami M, Masuo S, Sakiyama M, Kojima R, Hori A, et al. Graft-versus-host disease of the kidney after rapid tapering of cyclosporin following reduced intensity hematopoietic stem cell transplantation. Bone Marrow Transplant. 2005;35(9):929-30.
10. Panoskaltsis-Mortari A, Price A, Hermanson JR, Taras E, Lees C, Serody IS, et al. In vivo imaging of graft-versus-host-disease in mice. Blood. 2004;103(9):3590-8.
11. Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, Leitman S, et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med. 2000;343(11):750-8.
12. Kyle RA. Monoclonal proteins and renal disease. Annu Rev Med. 1994;45:71-7.
13. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15(6):825-8.
14. Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S, et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol. 1991;28(3):250-9.
15. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999;55(2):713-23.
16. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med. 1998;339(20):1448-56.
17. Ertault-Daneshpouy M, Leboeuf C, Lemann M, Bouhidel F, Ades L, Gluckman E, et al. Pericapillary hemorrhage as criterion of severe human digestive graft-versus-host disease. Blood. 2004;103(12):4681-4.
18. El-Seisi S, Gupta R, Clase CM, Forrest DL, Milandinovic M, Couban S. Renal pathology at autopsy in patients who died after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2003;9(11):683-8.
19. Harris KP, Hattersley JM, Feehally J, Walls J. Acute renal failure associated with haematological malignancies: a review of 10 years experience. Eur J Haematol. 1991;47(2):119-22.
20. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med. 1996;334(22):1448-60.
21. Perazella MA. Drug-induced nephropathy: an update. Expert Opin Drug Saf. 2005;4(4):689-706.
22. Shankel SW, Johnson DC, Clark PS, Shankel TL, O'Neil WM Jr. Acute renal failure and glomerulopathy caused by nonsteroidal anti-inflammatory drugs. Arch Intern Med. 1992;152(5):986-90.
23. Montseny JJ, Kleinknecht D, Meyrier A, Vanhille P, Simon P, Pruna A, et al. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies. Nephrol Dial Transplant. 1998;13(6):1438-45.
24. Moulin B, Ronco PM, Mougenot B, Francois A, Fillastre JP, Mignon F. Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas. Kidney Int. 1992;42(1):127-35.
25. Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM, et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant. 2003;3(6):708-14.
26. Biedermann BC, Sahner S, Gregor M, Tsakiris DA, Jeanneret C, Pober JS, et al. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease. Lancet. 2002;359(9323):2078- 83.
27. Dumler JS, Beschorner WE, Farmer ER, Di Gennaro KA, Saral R, Santos GW. Endothelial-cell injury in cutaneous acute graft-versus-host disease. Am J Pathol. 1989;135(6):1097-103.
28. Shimizu A, Meehan SM, Kozlowski T, Sablinski T, Ierino FL, Cooper DK, et al. Acute humoral xenograft rejection: destruction of the microvascular capillary endothelium in pig-to-nonhuman primate renal grafts. Lab Invest. 2000;80(6):815-30.
29. Braun MC, Stablein DM, Hamiwka LA, Bell L, Bartosh SM, Strife CF. Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience. J Am Soc Nephrol. 2005;16(7):2225-33.
30. Floege J. Recurrent IgA nephropathy after renal transplantation. Semin Nephrol. 2004;24(3):287-91.